Open House

Start your future in medicine today!

Register Now


Issue No 60.

Spring 2023




Assessing Clinical Outcomes and Monitoring A1C Levels in patients living with diabetes in Anguilla in Reference to the Aegle Glucose Monitoring Technology:

a Longitudinal Cohort Study

By: Rachel Beauielu, Amanda Lepkyj, Corvonn Peebles, Taha Al Youssif, Aseel Alhiri and Atemkeng Tazi

Mentor: Dr. Claude-Bernard Iliou


Type 2 diabetes is a rapidly growing health problem in the world. Continuous glucose monitoring (CGM) is an adjunct to diabetes management. There is strong evidence that CGM use in people with type 1 diabetes benefits in reducing glycated hemoglobin and hypoglycemic episodes with increased time in range. Evidence of the results of CGM use in type 2 diabetes is not so robust.

SJSM students wanted to evaluate the effects of CGM use on glycemic variability in patients with type 2 diabetes. If the obtained information benefits patients more than the standard of care – CGM use pulls diabetes management closer to personalized medicine with many other advantages.

Their research was a part of SJSM community activities, was supervised by local physicians, and there was no violation of ethical standards of research and publishing.


  • Stay Connected
--> --> -->